Entrinsic Health
2012
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Accelerator/Inc
LATEST DEAL TYPE
9
INVESTORS
Description
Developer of dietary supplements designed to address critical digestive health problems in humans and animals around the world. The company's supplements provide amino acids and electrolytes that help to manage gastrointestinal (GI) dysfunction that occurs from the treatment of cancer, by rebuilding and protecting the gastrointestinal tract delivering total body hydration, enabling patients to get relief from the side effects caused by chemotherapy or radiation therapy.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 100 River Ridge Drive
- Suite 206
- Norwood, MA 02062
- United States
+1 (781) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Entrinsic Health’s full profile, request a free trial.
Entrinsic Health Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 000.00 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 28-Aug-2018 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
| 5. Accelerator/Incubator | 000.00 | Completed | Startup | |||
| 4. Grant | 17-May-2016 | 000.00 | Completed | Startup | ||
| 3. Early Stage VC (Series B) | 04-Mar-2016 | 00.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Early Stage VC (Series A) | 31-Jan-2015 | $5.12M | $5.12M | 000.00 | Completed | Startup |
| 1. Grant | 01-Jan-2015 | $500K | Completed | Startup |
Entrinsic Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Entrinsic Health Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Space Biomedical Research Institute | Government | 000 0000 | 000000 0 | |||
| Johnson & Johnson | Corporation | Minority | 000 0000 | 000000 0 | ||
| Junonia Capital, LLC | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| SmartCap | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Enterade Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 |
Entrinsic Health Executive Team (10)
1 Former Executive
You’re viewing 5 of 10 executives. Get the full list »Entrinsic Health Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Brian Fox | Entrinsic Health | Board Member | 000 0000 | |
| Byron Kalogerou JD | McDermott Will & Emery | Board Member | 000 0000 | |
| Charlie Raffin | Entrinsic Health | Board Observer | 000 0000 | |
| Daniel Dennison Ph.D | Entrinsic Health | Board Member, Advisory Board Member & Chief Technology Officer | 000 0000 | |
| Jane Teague | Florida Institute for the Commercialization of Public Research | Board Observer | 000 0000 |
1 Former Board Member
You’re viewing 5 of 11 board members. Get the full list »